Education
About Us
Working with TipRanks
Follow Us
Emili Torrell Cortada Insider Profile
4 Followers
Emili Torrell Cortada, Chief Business Development Officer at Oryzon Genomics SA, holds ― shares in Oryzon Genomics SA (Ticker: DE:ORN). Most recently, Emili Torrell Cortada Sold €36,900 shares of Oryzon Genomics SA on Sep 27, 2022 for an estimated value of 84.87K.
Emili Torrell Cortada has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Emili Torrell Cortada does not currently own shares as a corporate insider.
A breakdown of Emili Torrell Cortada's holdings
Insider Roles
Chief Business Development Officer
Roles that Emili Torrell Cortada holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Emili Torrell Cortada
Emili Torrell Cortada's Trading History
List of latest transactions for each holding click on a transaction to see Emili Torrell Cortada's performance on stock
You May Also Like
Emili Torrell Cortada insider profile FAQ
What is the percentage of profitable transactions made by Emili Torrell Cortada?
The percentage of profitable transactions made by Emili Torrell Cortada is ―.
What is the average return per transaction made by Emili Torrell Cortada?
The average return per transaction made by Emili Torrell Cortada is ―.
What stocks does Emili Torrell Cortada hold?
Emili Torrell Cortada holds: DE:ORN stocks.
What was Emili Torrell Cortada’s latest transaction?
Emili Torrell Cortada latest transaction was an Informative Sell of €84.87K.
What was Emili Torrell Cortada's most profitable transaction?
Emili Torrell Cortada’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Emili Torrell Cortada's role in Oryzon Genomics SA?
Emili Torrell Cortada's role in Oryzon Genomics SA is Chief Business Development Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.